secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001493152-24-004251
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa Pharmaceuticals prices $7M public offering of 1.56M shares and warrants at $4.50 per unit
--------------------------------------------------------------------------------

- Pricing of 1,555,555 shares (or pre-funded warrants) and common warrants at $4.50 per unit; gross proceeds ~$7M.
- Common warrants exercisable at $4.50/share, immediately exercisable, 5-year term; pre-funded warrants at $0.0001.
- H.C. Wainwright & Co. as sole placement agent with 7.0% cash fee and placement agent warrants.
- Offering closed Jan 30, 2024; net proceeds for general corporate purposes.
- 90-day lock-up on equity issuance subject to exceptions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224004251/0001493152-24-004251-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224004251/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-004251

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer